Biocon, Asia's premier biotechnology company has received global recognition from the 'Science' Magazine which features Biocon in its annual Global 'Top Twenty Employer' list for the Bio-pharma sector. According to the 2012 Top Biotech and Pharma Employers survey, Biocon has been ranked at No 19. Biocon is the only Asian Company to be a part of the Top 20 Elite List, which includes leading global innovator companies.
These companies have been ranked on six key parameters - innovative leader in the industry, treat employees with respect, socially responsible, have loyal employees, does important quality research and makes changes needed.
This global ranking reflects the growing power of Brand Biocon, which is ably supported by its valuable partners, customers, employees and all other stake holders. Biocon is Asia’s leading R&D based Biotechnology Company. It produces anti-diabetic agents like Acarbose, Pioglitazone, Repaglinides and Rosiglitazone. In the biological segment it produces Insulin, Erythropoietin (EPO), Filgrastim (GCSF), Streptokinase and Monoclonal Antibodies. The drug major also produces mycophenolate mofetil, sirolimus and tacrolimus.
Company Name | CMP |
---|---|
Sun Pharma Inds. | 1821.20 |
Dr. Reddys Lab | 1179.60 |
Cipla | 1551.00 |
Lupin | 2088.35 |
Zydus Lifesciences | 882.30 |
View more.. |